BackVascular Biogenics Overview

Vascular Biogenics Other Assets

Vascular Biogenics's other assets is $0.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer average / median

Loading

Vascular Biogenics Other Assets History

Loading

Vascular Biogenics vs. peers: Other Assets Comparison

Loading

Vascular Biogenics Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Vascular Biogenics (VBLT) FAQ

As of the most recent data (June 2024), VBLT shows a other assets of $0. In the prior-year period, the figure was $0. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, VBLT's other assets is now $0 (was $0). Pairing that YoY change with peer averages gives a clearer picture of whether Vascular Biogenics is outperforming or lagging.

Tracking VBLT's other assets over time shows whether Vascular Biogenics is scaling, shrinking, or reshaping that part of the business. The current reading is $0 In the prior-year period, the figure was $0. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this other assets page, Stockcircle has Vascular Biogenics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect other assets (currently $0) with ownership activity and broader fundamentals.

Vascular Biogenics's other assets is $0; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.